In-licensing: Pharmaceuticals For Osteoporosis And Arthrosis

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Pharmaceuticals for osteoporosis and arthrosis; rx or OTC status

We are seeking pharmaceuticals to complement our existing portfolio within the osteoporosis and arthrosis areas

Preregistration

In-licensing opportunities for exclusive rights to sell and market the product in Finland.

Mr Raimo Skottman
Business Development Director

Leiras Finland Oy

Finnish pharmaceutical company focused upon Rx, OTC and generics.

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Industry sector: Biotechnology; Pharmaceutical / OTC/Non-Prescription; Pharmaceutical / Personal Care; Pharmaceutical; Pharmaceutical / Prescription
Therapeutic target: Musculoskeletal / Skeletal / Arthritis (non-specific); Musculoskeletal; Musculoskeletal / Skeletal / Osteoarthritis; Musculoskeletal / Skeletal / Osteoporosis; Musculoskeletal / Skeletal / Rheumatic disorders (other); Musculoskeletal / Skeletal / Rheumatoid arthritis

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.